FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 331:1372-1374 November 17, 1994 Number 20 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Acute renal failure is an important cause of morbidity and mortality. The annual incidence of severe acute renal failure in the United Kingdom is about 180 per million,¹ but substantial renal impairment may occur in up to 5 percent of patients undergoing major surgery. Because its management is so complex, acute renal failure has a high monetary cost, and because the mortality rate is over 90 percent in some groups of patients, the cost per survivor may be astronomical. The continuing challenge, therefore, is to prevent acute renal failure and, failing that, to develop therapeutic strategies to promote the recovery . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.